Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
eNq1mF1v2jAUhu/5FVHuSUi/sk6BamPthtRqjBZt2k1lkkMxM3Z6bFO6Xz+H0I1OjtoafBnbeX3s8/rxkbOz1YIFS0BJBe+GSdQJA+C5KCi/64bjm4v2u/Cs18rmZEm2hqVRJ0oOwiBnRMpuWPVGEyBcRj+uLj+B+R8w7LWCTEzmkKtn47SiLPpC5OyKlNWYIFsKWgQLUDNRdMNSq3VrkEmFJoreg8BfsiQ5ZPGmZbt3fnu03Z7FldgrVLUEvCT8zioK3Ekz14jAVZ8ouBP42BDvoZM2lSOQQmMOQ6JmQxRLWkBhnWJKmASnSaYPxTXgkoGqJrGKx/N8IZ3EyZysRnA/sAf9wfT21Uq1O+0kTZP0MElO0vTULbm4tVX2LJhFxPltkh4fdE6PYuBxzuiCSCW4Y3aGAhVhnvJCZf+5tTzNg3D/Yv4LKktGHqO5LF23iiAx3YAGAP4WUq3gBg2SmNmz//S5Zix+Y9TjDTA8RVzxqC80Vw3cuBi5bkRfcAWr5oy6oU6tNl6kIPcn+1twO+aHesJo7go1gx0NUo1Hg2am7RcHH4mEMfrjwXfKC/Eg98+Z7bx6ir5co9IqWmKR3B6cvjtJjo+dj9FPY6KGW+ZcoyghNgSichewDPhU7IoU40u71JMr92jIdbUjcsKgod5pO/LFOPGpPPPmdX/nqO6win4+v3E1yDcN+Hi9/rRK06L7N7Vu8PVBdGPHxsDfbu76jHuphDXa2TFTqpTv43hGZFsSs0PRFD2Qfes69VeFe7mz6xqmpqOn0Cf1tff6/LiesZdu9F2r1M3/m2rYOodCDTvkocaxN2gOzvfP4X8lqrewh8+44W+adTlJFBXcV5GjJ1bF3chv8sov0MDh63RKG15EGn2ZxfVrTK+VxdVLTK/1B2Le5P0=
bRuRfCMApvjj5ZGT
Listen
